Ad is loading...
ABGNX
Price
$19.86
Change
-$0.18 (-0.90%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

ABGNX vs RLEFX

Header iconABGNX vs RLEFX Comparison
Open Charts ABGNX vs RLEFXBanner chart's image
American Century Balanced R5
Price$19.86
Change-$0.18 (-0.90%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
ABGNX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABGNX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABGNX is a Buy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. ABGNX (938M). RLEFX pays higher dividends than ABGNX: RLEFX (2.42) vs ABGNX (1.88). ABGNX was incepted earlier than RLEFX: ABGNX (8 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. ABGNX (72.00). ABGNX has a lower initial minimum investment than RLEFX: ABGNX (0) vs RLEFX (250). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. ABGNX (18.97). RLEFX return over 5 years is better than : 35.95 vs. ABGNX (8.94).
ABGNXRLEFXABGNX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD12.33014.21187%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets938M236B0%
Annual Yield % from dividends1.882.4278%
Returns for 1 year18.9721.0990%
Returns for 3 years-11.2310.95-103%
Returns for 5 years8.9435.9525%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology